AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>
Results: 51-75/114

Authors: HIDDEMANN W SCHLEYER E UNTERHALT M KERN W BUCHNER T
Citation: W. Hiddemann et al., OPTIMIZING THERAPY FOR ACUTE MYELOID-LEUKEMIA BASED ON DIFFERENCES ININTRACELLULAR METABOLISM OF CYTOSINE-ARABINOSIDE BETWEEN LEUKEMIC BLASTS AND NORMAL MONONUCLEAR BLOOD-CELLS, Therapeutic drug monitoring, 18(4), 1996, pp. 341-349

Authors: GERDING H BUCHNER T BUSSE H
Citation: H. Gerding et al., DIRECT NONINVASIVE MEASUREMENT OF TEAR OXYGEN-TENSION BENEATH GAS-PERMEABLE CONTACT-LENSES IN RABBITS, Investigative ophthalmology & visual science, 37(10), 1996, pp. 1935-1936

Authors: DIEHL V BUCHNER T
Citation: V. Diehl et T. Buchner, ACUTE AND CHRONIC LEUKEMIA, Der Internist, 37(10), 1996, pp. 969-970

Authors: HOELZER D GOKBUGET N ARNOLD R BUCHNER T FREUND M GASSMANN W HEIL G HIDDEMANN W LOFFLER H LIPP T LUDWIG WD MASCHMEYER G THIEL E MESSERER D
Citation: D. Hoelzer et al., ACUTE LYMPHATIC-LEUKEMIA IN THE ADULT - D IAGNOSIS, RISK GROUPS AND TREATMENT, Der Internist, 37(10), 1996, pp. 994-1007

Authors: BUCHNER T
Citation: T. Buchner, ACUTE MYELOID-LEUKEMIA, Der Internist, 37(10), 1996, pp. 1008-1012

Authors: MULLER C KREMERSKOTHEN J ZUHLSDORF M CASSENS U BUCHNER T BARNEKOW A KOCH OM
Citation: C. Muller et al., RAPID QUANTITATIVE-ANALYSIS OF PROTEIN-TYROSINE RESIDUE PHOSPHORYLATION IN DEFINED CELL-POPULATIONS IN WHOLE-BLOOD AND BONE-MARROW ASPIRATES, British Journal of Haematology, 94(3), 1996, pp. 461-463

Authors: SCHOCH C HAASE D HAFERLACH T FREUND M LINK H LENGFELDER E LOFFLER H BUCHNER T FONATSCH C
Citation: C. Schoch et al., INCIDENCE AND IMPLICATION OF ADDITIONAL CHROMOSOME-ABERRATIONS IN ACUTE PROMYELOCYTIC LEUKEMIA WITH TRANSLOCATION T(15-17)(Q22-Q21) - A REPORT ON 50 PATIENTS, British Journal of Haematology, 94(3), 1996, pp. 493-500

Authors: BUCHNER T HIDDEMANN W WORMANN B ZUHLSDORF M ASWALD J ASWALD S ROTTMANN R MASCHMEIER G LUDWIG WD SAUERLAND MC HEINECKE A
Citation: T. Buchner et al., AGE AND KAROTYPE-DEPENDENT EFFECT OF GM-CSF MULTIPLE COURSE PRIMING IN AML, Blood, 88(10), 1996, pp. 844-844

Authors: BUCHNER T HIDDEMANN W WORMANN B LOFFLER H GASSMANN W HAFERLACH T HEYLL A AUL T LENGFELDER E MASCHMEYER G LUDWIG WD SAUERLAND MC HEINECKE A
Citation: T. Buchner et al., INTENSIVE CONSOLIDATION VERSUS PROLONGED MAINTENANCE FOLLOWING INTENSIVE INDUCTION AND CONVENTIONAL CONSOLIDATION IN PRIMARY AML - A STUDY BY AMLCG, Blood, 88(10), 1996, pp. 846-846

Authors: ZUHLSDORF M BRANDT M BUCHNER T
Citation: M. Zuhlsdorf et al., PRIMARY ARA-C RESISTANCE OF AML PROGENITOR CELLS - IN-VITRO ASSAY VALIDATED BY CLINICAL-RESULTS, Blood, 88(10), 1996, pp. 1434-1434

Authors: GRIESINGER F PIRONOACK M FALK M KALB N PUSCHEL M TROFF C GROVE D BUCHNER T RITTER J HIDDEMANN W WORMANN B
Citation: F. Griesinger et al., HIGH PREDICTIVE VALUE FOR RELAPSE BY 3-COLOR-FLOW-CYTROMETRIC DETECTION OF LEUKEMIA-ASSOCIATED IMMUNOPHENOTYPE (LAIP) POSITIVE CELLS IN ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL), Blood, 88(10), 1996, pp. 1901-1901

Authors: JAHNSSTREUBEL G HAASE D SCHOCH C WORMANN B BUCHNER T FONATSCH C HIDDEMANN W
Citation: G. Jahnsstreubel et al., CYTOGENETIC SUBGROUPS OF ACUTE MYELOID-LEUKEMIA (AML) DIFFER SIGNIFICANTLY IN PROLIFERATIVE ACTIVITY - CYTOKINE PRODUCTION AND SENSITIVITY TO GM-CSF STIMULATION, Blood, 88(10), 1996, pp. 2229-2229

Authors: SCHOCH C HAASE D FONATSCH C HAFERLACH T SCHLEGELBERGER B HOSSFELD DK BECHER R SAUERLAND MC WORMANN B HIDDEMANN W BUCHNER T
Citation: C. Schoch et al., THE PROGNOSTIC IMPACT OF TRISOMY-8 IN ACUTE MYELOID-LEUKEMIA - COULD INTERPHASE CYTOGENETICS PROVIDE SUFFICIENT INFORMATION, Blood, 88(10), 1996, pp. 2234-2234

Authors: HOELZER D LUDWIG WD THIEL E GASSMANN W LOFFLER H FONATSCH C RIEDER H HEIL G HEINZE B ARNOLD R HOSSFELD D BUCHNER T KOCH P FREUND M HIDDEMANN W MASCHMEYER G HEYLL A AUL C FAAK T KUSE R ITTEL TH GRAMATZKI M DIEDRICH H KOLBE K FUHR HG FISCHER K SCHADECKGRESSEL C WEISS A STROHSCHEER I METZNER B FABRY U GOKBUGET N VOLKERS B MESSERER D UBERLA K
Citation: D. Hoelzer et al., IMPROVED OUTCOME IN ADULT B-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA, Blood, 87(2), 1996, pp. 495-508

Authors: SPERLING C BUCHNER T CREUTZIG U RITTER J HARBOTT J FONATSCH C SAUERLAND C MIELCAREK M MASCHMEYER G LOFFLER H LUDWIG WD
Citation: C. Sperling et al., CLINICAL, MORPHOLOGIC, CYTOGENETIC AND PROGNOSTIC IMPLICATIONS OF CD34 EXPRESSION IN CHILDHOOD AND ADULT DE-NOVO AML, Leukemia & lymphoma, 17(5-6), 1995, pp. 417-426

Authors: HIDDEMANN W BUCHNER T
Citation: W. Hiddemann et T. Buchner, RATIONALE FOR HIGH-DOSE CHEMOTHERAPY AND APPLICATION OF HEMATOPOIETICGROWTH-FACTORS IN ACUTE MYELOID-LEUKEMIA, Annals of oncology, 6, 1995, pp. 27-31

Authors: VONEIFF M ZUHLSDORF M ROOS N THOMAS M BUCHNER T VANDELOO J
Citation: M. Voneiff et al., PULMONARY-INFILTRATES IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES - CLINICAL USEFULNESS OF NONINVASIVE BRONCHOSCOPIC PROCEDURES, European journal of haematology, 54(3), 1995, pp. 157-162

Authors: JAHNSSTREUBEL G REUTER C UNTERHALT M SCHLEYER E WORMANN B BUCHNER T HIDDEMANN W
Citation: G. Jahnsstreubel et al., BLAST CELL PROLIFERATIVE ACTIVITY AND SENSITIVITY TO CM-CSF IN-VITRO ARE ASSOCIATED WITH EARLY RESPONSE TO TAD-9 INDUCTION THERAPY IN ACUTEMYELOID-LEUKEMIA, Leukemia, 9(11), 1995, pp. 1857-1863

Authors: JAHNSSTREUBEL G REUTER C UNTERHALT M WORMANN B BUCHNER T HIDDEMANN W
Citation: G. Jahnsstreubel et al., BLAST CELL PROLIFERATIVE ACTIVITY AND SENSITIVITY TO GM-CSF IN THE CONTEXT OF CULTURE CONDITIONS AND AUTONOMOUS GROWTH-FACTOR PRODUCTION INACUTE MYELOID-LEUKEMIA (AML), Experimental hematology, 23(8), 1995, pp. 933-933

Authors: SPERLING C SCHWARTZ S MAURER J HEINECKE A BUCHNER T ZIMMERMANN M CREUTZIG U BUHRING HJ SCHOCH C FONATSCH C LOFFLER H HOELZER D THIEL E HERRMANN F LUDWIG WD
Citation: C. Sperling et al., CD117 EXPRESSION IS RESTRICTED TO MYELOID AND EARLY T-LINEAGE DIFFERENTIATION IN ACUTE-LEUKEMIA AND LACKS PROGNOSTIC-SIGNIFICANCE IN AML, Blood, 86(10), 1995, pp. 147-147

Authors: SCHOCH C HAASE D HAFERLACH T BUCHNER T FREUND M LINK H LOFFLER H FONATSCH C
Citation: C. Schoch et al., SECONDARY CHROMOSOME-ABERRATIONS IN ACUTE MYELOID-LEUKEMIA WITH T(8-21)(Q22-Q22), INV(16)(P13Q22) OR T(15-17)(Q22-Q21), Blood, 86(10), 1995, pp. 160-160

Authors: HAFERLACH T LOFFLER H GASSMANN W SCHOCH R FONATSCH C SCHOCH C SCHLEGELBERGER B LUDWIG WD THIEL E BECHER R HEINECKE A SAUERLAND MC BUCHNER T
Citation: T. Haferlach et al., TRILINEAGE DYSPLASIA (TLD) IS CORRELATED WITH A BAD PROGNOSIS IN DE-NOVO ACUTE MYELOID-LEUKEMIA (AML) - FIRST RESULTS OF A PROSPECTIVE-STUDY FROM THE GERMAN AMLCG-TRIAL, Blood, 86(10), 1995, pp. 165-165

Authors: GAHN B HAASE D UNTERHALT M DRESCHER M SCHOCH C FONATSCH C TERSTAPPEN LWMM HIDDEMANN W BUCHNER T WORMANN B BENNETT JM
Citation: B. Gahn et al., DE-NOVO AML WITH DYSPLASTIC HEMATOPOIESIS - CORRELATION WITH CYTOGENETIC ABNORMALITIES AND PROGNOSIS, Blood, 86(10), 1995, pp. 166-166

Authors: HIDDEMANN W FONATSCH C WORMANN B HEINECKE A SAUERLAND C SCHARNHORST S BUCHNER T
Citation: W. Hiddemann et al., CYTOGENETIC SUBGROUPS OF AML AND OUTCOME FROM HIGH-DOSE VERSUS CONVENTIONAL-DOSE ARA-C AS PART OF DOUBLE INDUCTION THERAPY, Blood, 86(10), 1995, pp. 1054-1054

Authors: WORMANN B KONEMANN S GROVE D TOEPKER S SAUERLAND AHB BUCHNER T HIDDEMANN W TERSTAPPEN LWMM
Citation: B. Wormann et al., MINIMAL RESIDUAL DISEASE IN ADULTS WITH DE-NOVO AML, Blood, 86(10), 1995, pp. 1313-1313
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>